Open AccessElectroacupuncture for post-stroke dysphagia
Author(s) -
Chang-ho Han,
Jeong Hwa Kim,
Mi-Kyung Kim,
Ha-ri Kim,
Seoyoung Kim,
HyeYeon Choi,
Chul Jin,
Seungwon Kwon,
Woo-Sang Jung,
Sang-Kwan Moon,
Jung-Mi Park,
Chang-Nam Ko,
SeungYeon Cho
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000022360
Subject(s) - medicine , cochrane library , electroacupuncture , dysphagia , medline , meta analysis , randomized controlled trial , stroke (engine) , adverse effect , physical therapy , systematic review , acupuncture , intensive care medicine , alternative medicine , surgery , mechanical engineering , pathology , political science , law , engineering
Background: Post-stroke dysphagia (PSD) requires effective treatment as it may cause aspiration pneumonia, dehydration, or malnutritution, which can increase the length of hospital stay as well as mortality. In the field of stroke, electroacupuncture (EA) has been widely used, and a number of clinical research papers have been published regarding its effects. This systematic review aims to evaluate the effectiveness of EA for the treatment of PSD. Methods: Randomized controlled trials evaluating the use of EA in PSD will be included in this meta-analysis. The following electronic databases will be searched from inception to July 31, 2020, using terms relating to EA and PSD: PubMed, the Cochrane Library, the Excerpta Medica Database, China National Knowledge Infrastructure, the Korean Medical Database, KoreaMed, the National Digital Science Library, and the Oriental Medicine Advanced Searching Integrated System. Two reviewers will independently search these databases, select studies for inclusion, and evaluate the quality of the studies. Methodological quality will be assessed using the Cochrane Handbook for Systematic Reviews of Interventions (version 6.0). The primary outcome will be the total effective rate; secondary outcomes will include results of other assessments of dysphagia such as the water drinking test scale and videofluoroscopic swallowing study. We will also investigate the number and severity of adverse events. The Cochrane Review Manager (RevMan) software (version 5.3.5) will be employed to assess bias risk, data integration risk, and meta-analysis risk. Mean difference and standardized mean difference will be used to represent continuous data, while risk ratios will be used for pooled binary data. Results: This study will provide a comprehensive review and evaluation of the available evidence regarding the efficacy and safety of EA as a treatment for PSD. Conclusion: This study will clarify whether EA could be an effective and safe treatment for PSD.